Analyses of minimal residual disease based on Flt3 mutations in allogeneic peripheral blood stem cell transplantation
2005
Purpose
Activating Flt3 mutations are observed in about 30% of patients with acute myeloid leukaemia (AML) and individual Flt3 mutations are applicable for minimal residual disease (MRD) analyses.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
8
Citations
NaN
KQI